What Is ARA-290 (Cibinetide)? Research, EPOR/CD131 Signaling & Repair Pathways

ARA-290, also known as Cibinetide, is a research peptide studied for its interaction with cellular signaling systems associated with tissue stress, inflammatory responses and repair-related biological processes.

Unlike research compounds centered primarily on metabolic receptors, ARA-290 is commonly investigated in models designed to help researchers understand how cells respond when tissue experiences stress or disruption.

A major focus of ARA-290 research is a receptor complex known as EPOR/CD131, which is also referred to in scientific literature as the innate repair receptor.

This guide explains ARA-290 research in straightforward language, including what Cibinetide is, where it came from, what EPOR/CD131 means and why researchers investigate this peptide in repair and cellular-response models.

What Is ARA-290?

ARA-290 is a short synthetic peptide derived from a region of the naturally occurring protein erythropoietin (EPO).

EPO is widely known for its involvement in red blood cell biology. However, scientists discovered that EPO-related biology also involves another signaling pathway associated with how certain cells respond to stress and tissue disruption.

ARA-290 was developed to allow researchers to investigate this alternative signaling system without focusing on the traditional red-blood-cell pathway associated with EPO.

Is ARA-290 the Same as Cibinetide?

ARA-290 and Cibinetide refer to the same research peptide.

Both names appear throughout scientific literature, which makes them important search terms when researching the compound.

A literature search for ARA-290 may therefore also include:

• ARA-290
• ARA 290
• ARA290
• Cibinetide
• EPOR/CD131
• Innate repair receptor

What Is the EPOR/CD131 Receptor?

One of the most important concepts in ARA-290 research is the EPOR/CD131 receptor complex.

The terminology sounds complicated, but the basic research concept is easier to understand.

Cells use receptors to receive biological signals. EPOR/CD131 is a receptor complex researchers study in connection with the way cells communicate during conditions involving stress, inflammation and tissue disruption.

Scientific literature sometimes calls this receptor complex the innate repair receptor.

ARA-290 is studied for its interaction with this receptor system, making EPOR/CD131 signaling a central part of ARA-290 research.

Why Is ARA-290 Studied in Repair Research?

Cells do not simply switch from a normal state to a damaged state. They communicate continuously through signaling pathways that help coordinate responses to changes in their environment.

When tissue is under stress, several biological processes may occur at the same time. Researchers may observe changes involving inflammatory signaling, oxidative stress, cellular survival pathways and repair-associated communication.

ARA-290 provides researchers with a way to investigate how EPOR/CD131-associated signaling participates in these responses.

For this reason, ARA-290 is commonly associated with repair and tissue-response research.

What Is ARA-290 Commonly Researched For?

Experimental research involving ARA-290 and Cibinetide has included investigation of:

• EPOR/CD131 receptor signaling
• Innate repair receptor research
• Cellular stress-response pathways
• Tissue-response signaling
• Inflammatory signaling
• Oxidative-stress research
• Cellular survival pathways
• Cell-to-cell communication
• Endothelial cell research
• Neural and peripheral tissue research

ARA-290 and Cellular Stress Research

Cellular stress occurs when cells encounter conditions that challenge their normal biological environment.

Researchers study how cells detect these conditions and how signaling pathways respond.

Published experimental research has examined ARA-290 in connection with the EPO/CD131 receptor complex and cellular stress responses, including inflammatory and oxidative-stress conditions.

This provides researchers with a model for studying how stress-related cellular signals may interact with repair-associated pathways.

ARA-290 and Inflammatory Signaling Research

Inflammation is another major area associated with ARA-290 research.

Inflammatory signaling is part of the biological response to many forms of cellular and tissue stress. Researchers investigate how inflammatory signals are activated, amplified and eventually regulated.

Experimental studies involving Cibinetide have examined its interaction with signaling pathways associated with inflammatory responses and CD131-dependent activity.

These findings make inflammatory-response signaling an important component of the broader ARA-290 research landscape.

ARA-290 and Tissue-Response Research

Another important research area involves the way cells respond after tissue disruption.

Researchers may examine cellular migration, signaling between cells, oxidative stress, inflammatory activity and other biological responses occurring within experimental tissue models.

ARA-290 has been studied in several types of preclinical models to better understand the relationship between EPOR/CD131 signaling and these tissue-response mechanisms.

Is ARA-290 an EPO Peptide?

ARA-290 is derived from a region of erythropoietin, but it should not simply be described as EPO.

It is a short peptide designed around a specific region associated with alternative EPO-related signaling.

This distinction is important because much of ARA-290 research focuses on EPOR/CD131-associated pathways rather than the classical erythropoietic signaling responsible for red blood cell production.

Why Researchers Study ARA-290

ARA-290 is particularly interesting because it provides researchers with a relatively focused way to investigate a specific cellular signaling system.

Rather than thinking of ARA-290 simply as a “repair peptide,” it is more accurate to understand it as a research peptide used to investigate how cells communicate and respond during stress, inflammation and tissue disruption.

That distinction is important because research pathways describe biological questions being investigated—not established outcomes.

Frequently Asked Questions About ARA-290

What is ARA-290?

ARA-290 is an EPO-derived research peptide studied primarily in connection with EPOR/CD131 signaling and cellular responses involving stress, inflammatory and tissue-response pathways.

What is another name for ARA-290?

ARA-290 is also known as Cibinetide.

What is the innate repair receptor?

The term innate repair receptor is used in scientific literature for a receptor complex involving EPOR and CD131. This signaling system is an important target in ARA-290 research.

Is ARA-290 studied for repair?

ARA-290 appears in experimental research involving repair-associated signaling, tissue responses, cellular stress and inflammatory pathways. These research areas should not be interpreted as established therapeutic effects.

Is ARA-290 a peptide?

Yes. ARA-290 is a short EPO-derived peptide and is also known as Cibinetide.

ARA-290 Research: Key Takeaway

ARA-290 provides researchers with a tool for investigating how cells communicate during conditions involving tissue stress and inflammatory activity.

Its association with the EPOR/CD131 receptor complex places it within an interesting area of research involving cellular stress responses, tissue signaling and repair-associated biological pathways.

Understanding the terms ARA-290, Cibinetide, EPOR/CD131 and innate repair receptor provides a strong starting point for researchers reviewing the scientific literature surrounding this compound.